Arezoo Astanehe

1.1k citations

18 papers · 913 indexed · h-index 14

Impact in

Oncology top 10%
- Cancer Cells and Metastasis
Cancer Research

Papers in

Oncology 12
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
Immunology and Allergy 2

Co-authors: Sandra E. Dunn Anna L. Stratford Kaiji Hu Abbas Fotovati Connie J. Eaves Karen To Isabelle M. Berquin Ashleen Shadeo
Journals: Oncogene (4 papers)Cancer Research (3 papers)Journal of Cell Science (2 papers)PLoS ONE (2 papers)Stem Cells (1 paper)
Partner nations: Canada United States Germany

In The Last Decade

Arezoo Astanehe

18 papers receiving 900 citations

Peers

Countries citing papers authored by Arezoo Astanehe

Since Specialization

Citations

This map shows the geographic impact of Arezoo Astanehe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezoo Astanehe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezoo Astanehe more than expected).

Fields of papers citing papers by Arezoo Astanehe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arezoo Astanehe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezoo Astanehe. The network helps show where Arezoo Astanehe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Arezoo Astanehe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arezoo Astanehe Line = papers co-authored together Arezoo Astanehe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Expression of Concern: Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer Journal of Cell Science ·Arezoo Astanehe, David J. Arenillas, Wyeth W. Wasserman, Peter C. K. Leung, Sandra E. Dunn, Barry R. Davies, Gordon B. Mills, Nelly Auersperg	2020	1
2	An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective Plastic & Reconstructive Surgery Global Open ·Arezoo Astanehe, Claire Temple‐Oberle, Maria Gullo, Anna Klein, Robert Lindsay, J. L. Matthews, Riad Haïdar, Justin Yeung, Christiaan Schrag	2018	79
3	Order Sets for Enhanced Recovery After Surgery Protocol Plastic & Reconstructive Surgery Global Open ·Melissa Shea‐Budgell, Christiaan Schrag, Danielle O. Dumestre, Arezoo Astanehe, Claire Temple‐Oberle	2017	8
4	Extracutaneous melanoma epidemiology in British Columbia Melanoma Research ·Emircan KOÇ, Milton Benevides de Freitas, Arezoo Astanehe, Tim K. Lee, Sunil Kalia	2014	13
5	YB-1 Transforms Human Mammary Epithelial Cells Through Chromatin Remodeling Leading to the Development of Basal-Like Breast Cancer Stem Cells ·Alastair Davies, Kristen M. Reipas, Mary Rose Pambid, 良憲平野, Anna L. Stratford, Abbas Fotovati, И.Н. Матвеева, Arezoo Astanehe, Kaiji Hu, Christopher A. Maxwell, Gordon B. Mills, Sandra E. Dunn	2014	36
6	Non-Invasive Imaging of Phosphoinositide-3-Kinase-Catalytic-Subunit-Alpha (PIK3CA) Promoter Modulation in Small Animal Models PLoS ONE ·Snehal Gaikwad, Ewa Kaznowska, Yohanes probo Sasongko, Arezoo Astanehe, Sanjiv S. Gambhir, Pritha Ray	2013	20
7	Abstract 506: Targeting Y-box binding protein-1 (YB-1) overcomes drug resistance in triple-negative breast cancer. Cancer Research ·Kristen M. Reipas, Anna L. Stratford, Arezoo Astanehe, Kaiji Hu, Sandra E. Dunn	2013	2
8	MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition Oncogene ·Arezoo Astanehe, J. E. Berthold, Martin Krzywinski, Abbas Fotovati, D H Kim, Isabelle M. Berquin, Gordon B. Mills, Marco A. Marra, Sandra E. Dunn	2012	47
9	Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance Cancer Research ·Karen To, Abbas Fotovati, Kristen M. Reipas, Jennifer Law, Kaiji Hu, Jing Wang, Arezoo Astanehe, Alastair Davies, Lawrence Lee, Anna L. Stratford, Afshin Raouf, Pauline Johnson, Isabelle M. Berquin, Hans‐Dieter Royer, Connie J. Eaves, Sandra E. Dunn	2010	144
10	Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability PLoS ONE ·Jennifer Law, Yvonne Li, Karen To, Michelle Wang, Arezoo Astanehe, Karen Lambie, D H Kim, Steven J.M. Jones, Martin Gleave, Connie J. Eaves, Sandra E. Dunn	2010	43
11	The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells Oncogene ·D H Kim, Arezoo Astanehe, Kuo Wang, Abbas Fotovati, Kaiji Hu, Sandra E. Dunn	2010	44
12	Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells Oncogene ·J. E. Berthold, Arezoo Astanehe, Karen To, Abbas Fotovati, Alastair Davies, Yun Zhao, Helen Jiang, Anna L. Stratford, Ashleen Shadeo, Carla Boccaccio, Paolo M. Comoglio, Peter R. Mertens, Peter Eirew, Afshin Raouf, Connie J. Eaves, Sandra E. Dunn	2009	81
13	The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1 Oncogene ·Arezoo Astanehe, J. E. Berthold, Payman Hojabrpour, Karen To, Abbas Fotovati, Ashleen Shadeo, Anna L. Stratford, Wan L. Lam, Isabelle M. Berquin, Vincent Duronio, Sandra E. Dunn	2009	64
14	Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice Cancer Research ·Cathy Lee, D H Kim, 段寅生, Yuanyuan Gao, Kaiji Hu, Eugene Park, Arezoo Astanehe, Mien‐Chie Hung, Peter Eirew, Connie J. Eaves, Sandra E. Dunn	2008	97
15	Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer Journal of Cell Science ·Arezoo Astanehe, David J. Arenillas, Wyeth W. Wasserman, Peter C. K. Leung, Sandra E. Dunn, Barry R. Davies, Gordon B. Mills, Nelly Auersperg	2008	66
16	THE TRANSCRIPTION FACTOR Y-BOX BINDING PROTEIN-1 (YB-1) INDUCES EXPRESSION OF THE PIK3CA ONCOGENE LEADING TO INCREASED INVASION OFBASAL-LIKE BREAST CARCINOMA CELLS Clinical and investigative medicine ·Arezoo Astanehe, J. E. Berthold, Karen To, Sandra E. Dunn	2008	1
17	Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy Breast Cancer Research ·Anna L. Stratford, Golareh Habibi, Arezoo Astanehe, Helen Jiang, Kaiji Hu, Eugene Park, Ashleen Shadeo, Timon P.H. Buys, Wan L. Lam, Trevor J. Pugh, Marco A. Marra, Torsten O. Nielsen, U. Klinge, Peter R. Mertens, Samuel Aparício, Sandra E. Dunn	2007	122
18	YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression. PubMed ·Joyce C. Wu, Anna L. Stratford, Arezoo Astanehe, Sandra E. Dunn	2007	45

About Arezoo Astanehe

Arezoo Astanehe is a scholar working on Oncology, Immunology and Allergy, Molecular Biology, Cell Biology and Reproductive Medicine, having authored 18 papers that have together received 913 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Cells and Metastasis (3 papers), Enhanced Recovery After Surgery (2 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (291 citations), Cancer Research (144 citations), Molecular Biology (622 citations), Pathology and Forensic Medicine (85 citations) and Immunology and Allergy (28 citations). Arezoo Astanehe has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Sandra E. Dunn, Anna L. Stratford, Kaiji Hu, Abbas Fotovati, Connie J. Eaves, Karen To, Isabelle M. Berquin, Ashleen Shadeo, Alastair Davies and Gordon B. Mills. Their work appears in journals such as Oncogene, Cancer Research, Journal of Cell Science, PLoS ONE and Stem Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact